ASCO Guidelines

180 Episodio

1. Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update

   Pubblicato: 29/07/2021
2. Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guidelin

   Pubblicato: 29/07/2021
3. Telehealth in Oncology: Standards and Practice Recommendations

   Pubblicato: 28/07/2021
4. Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline

   Pubblicato: 20/07/2021
5. Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline

   Pubblicato: 19/07/2021
6. Oncology Medical Home: ASCO and COA Standards

   Pubblicato: 13/07/2021
7. Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer Resource Stratified Guideline

   Pubblicato: 29/06/2021
8. Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer Guideline Update

   Pubblicato: 03/05/2021
9. Management of Salivary Gland Malignancy Guideline

   Pubblicato: 26/04/2021
10. Management of Dyspnea in Advanced Cancer Guideline

    Pubblicato: 22/02/2021
11. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update

    Pubblicato: 16/02/2021
12. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline

    Pubblicato: 28/01/2021
13. Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement

    Pubblicato: 27/01/2021
14. Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

    Pubblicato: 26/01/2021
15. PREVIEW: ASCO in Action CEO & CMO Interview

    Pubblicato: 19/01/2021
16. Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma: CSCO-ASCO Guideline

    Pubblicato: 06/01/2021
17. Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline

    Pubblicato: 16/11/2020
18. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Update

    Pubblicato: 20/10/2020
19. Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline

    Pubblicato: 01/10/2020
20. PARP Inhibitors in the Management of Ovarian Cancer Guideline

    Pubblicato: 13/08/2020